Saturday, June 15, 2024

Two executives of a telehealth company that distributed A.D.H.D. drugs were indicted on charges of health care fraud


[They were] arrested and accused of participating in a scheme to distribute Adderall and other stimulants for A.D.H.D. to patients who did not need the medications, and to bill insurers for these drugs


[The CEO's social media] posts frequently featured young people “discovering” on camera that they had A.D.H.D. 


[The company] one of several telehealth companies that became popular during pandemic lockdowns in 2020, when the government relaxed restrictions around online prescriptions for controlled substances such as Adderall. Those looser regulations meant that clinicians could prescribe medications virtually without first conducting an in-person evaluation